Regulating Artificial Intelligence

Narrow Focus Allows Pragmatica-Lung Trial to Minimize Eligibility Criteria, Significantly Reduce Data Collection, Researcher Says

Funding Opportunities for Innovative Multidisciplinary Cancer Research Teams

US FDA’s Review of Single-Country ‘Me Too’ Drugs: A Clinical Trialist Perspective

Proposed Criteria for Tumor Invasion Align with Clinical Factors, Offer Better Predictability, Study Finds

… Researchers evaluating the clinical significance of …

Pragmatic Approach to Trial Design Born from Lung-MAP Substudy

Real-World Data from Taiwan Shows Stage Shift Has Improved Lung Cancer Survival Rates

US FDA Grants Breakthrough Therapy Designation for Novel TKI Targeting HER2, EGFR

… In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited …

Recurrence Remains a Risk Even for Patients Diagnosed via Screening

… immunotherapy and improved novel and targeted therapies. Research evaluating the survival benefit of early recurrence …